Developer docs
API playgroundTry for free, no card

Search company profiles

Athelas

Full company profile

uuid00002nw

Namestring
Athelas
Legal namestring
Athelas, LLC
Websiteurl
athelas.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Athelas is a Mountain View, California-based healthcare AI company operating as a wholly-owned subsidiary of Commure, founded in 2016 and acquired by Commure in October 2023. The company has evolved from its origins in remote patient monitoring into an integrated, AI-native platform spanning five core products: Athelas Air (an EHR with embedded AI receptionist, scheduling, compliance checks, and patient portal), Ambient AI (a clinical documentation co-pilot and autonomous coding layer), RCM (Revenue Cycle Management with AI Denial Defense, Remittance Recon Agents, AI browser agents, and a configurable rules engine running dozens of automations), Athelas Home (an FDA 510(k)-cleared, CLIA-waived point-of-care hematology analyzer using on-device computer vision and a deep-learning model), and Athelas Agents (a suite of autonomous AI agents for scheduling, billing, appeals, and patient outreach). The platform is built on an ONC (g)(10) certified FHIR R4B API with US Core 6.1.0 compliance and integrates with more than 60 EHR systems, processing tens of billions of dollars in annual payments and supporting tens of millions of appointments per year with more than 85% of RCM work completed without a human in the loop.

Athelas serves a dual-segment customer base: large enterprise health systems (130+ of the nation's largest, including HCA Healthcare and Tenet Healthcare) and mid-market specialty physician practices across physical therapy, orthopedics, dermatology, urology, ENT, gastroenterology, urgent care, podiatry, and FQHCs. The company employs 101–250 people (with Forward Deployed Engineering teams supporting implementation), and in May 2026 announced a $70 million financing at a $7 billion post-money valuation led by General Catalyst, with participation from Sequoia Capital, Morgan Stanley, and Kirkland & Ellis, to scale R&D in agentic AI and expand into global healthcare markets.

The business model combines multi-product SaaS subscriptions (Air, Ambient AI, RCM, Agents), performance- and transaction-based RCM fees (denial management, patient collections, SmartPay), and hardware sales for Athelas Home devices deployed in homes, ambulatory settings, and pharmacies. Pricing is custom and quote-based, segmented by provider count and product bundle, sold primarily through direct enterprise field sales, inside-sales for mid-market practices, industry conference presence, and technology partnerships (e.g., Clinekt Health, Cape Cod Rehab). Customer outcomes reported in published case studies include 95% first-pass claim rates, 50% denial reductions, and tens to hundreds of thousands of dollars in monthly revenue gains, supporting land-and-expand economics across multi-site provider groups.

Short descriptiontext

Athelas is a Commure-owned healthcare AI subsidiary that provides an integrated platform combining RCM, an EHR (Air), ambient AI scribing, AI agents, and an FDA-cleared hematology analyzer, serving 500+ healthcare organizations across 3,000+ sites of care including HCA and Tenet.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersMountain View, United States
HQ citystring
Mountain View
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
revenue cycle management, electronic health records, ambient clinical documentation, AI medical scribing, healthcare automation platform
Industry4 codes
1EHR/EMR Integration & Interoperability Middleware (HL7/FHIR)
CodeHLALAKADPrimaryYes
2EHR Extensions, APIs, App Marketplaces & SMART-on-FHIR Apps
CodeHLACAAANPrimaryNo
3Medical-Grade Device Connectivity & Device Management (MDM)
CodeHLACAFAGPrimaryNo
4RPM Reimbursement, Billing & Program Operations Platforms
CodeHLACAFANPrimaryNo
NAICS code2 codes
  • Software Publishers513210
  • Software Publishers5132
SIC code2 codes
  • Services-Prepackaged Software7372
  • Surgical & Medical Instruments & Apparatus3841
Product category
Healthcare Practice Management Software
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model5 records
1Platform Subscription (RCM + Ambient AI + Air EHR + Agents)
TypeSubscription Recurring
Description

Recurring SaaS subscriptions across the integrated Athelas/Commure platform covering RCM tools, Ambient AI scribing, the Air EHR, and Athelas Agents, sold as a multi-product platform with upsell across modules.

athelas.com
2RCM Managed Services / Performance-based Fees
TypeManaged Services
Description

End-to-end revenue cycle management services for healthcare practices (Athelas RCM), including claim submission, denial management, patient responsibility collections, and reporting; includes performance-driven components tied to collections, recoveries, and automation rates.

athelas.com
3Athelas Home Diagnostics Device Sales / Deployment
TypeHardware Sales
Description

Revenue tied to the FDA-cleared Athelas Home CLIA-waived hematology analyzer deployed in home and point-of-care settings (ambulatory providers, pharmacies), enabling frequent Absolute Neutrophil Count testing for chemotherapy, immunosuppressive therapy, and Clozapine patients.

globenewswire.com
4Enterprise Health System Licensing
TypeSubscription Recurring
Description

Large-scale enterprise deployments inside health systems (130+ of the largest including HCA Healthcare and Tenet Healthcare), processing tens of billions of dollars in annual payments; includes expansion to global healthcare markets.

athelas.com
5Patient Responsibility Collections / SmartPay
TypeTransaction Fee
Description

Athelas handles patient responsibility collection flows (including SmartPay technology, bulk auto-charging of saved cards, and in-office collection workflows), generating a percentage-based or transaction-based component of revenue tied to patient balances collected.

athelas.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure
Pricing details1 tier
1Custom quote-based pricing by product bundle and provider count
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing varies by product (RCM, Ambient AI, Air, Athelas Home, Agents) and practice size (1-5 to 100+ providers); sales-led engagement with demo required. RCM pricing includes performance/collections-linked components and managed services.

athelas.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 5 records shown
1Athelas Ambient AI
Description

Ambient AI scribe and clinical documentation/coding suite (formerly Scribe).

athelas.com
+4 more records
Core offering1 text field

Athelas develops an AI-native healthcare practice platform that unifies revenue cycle management (RCM), an electronic health record (Air EHR), ambient AI clinical documentation, AI workflow agents, and an FDA-cleared CLIA-waived hematology analyzer (Athelas Home). The platform is sold primarily to U.S. health systems and specialty physician practices to automate claims, denial management, charting, scheduling, and patient communications.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Athelas operates as a multi-module healthcare AI platform unified under the Commure parent company, with five core product lines that fit together as an integrated offering. The platform centers on Air EHR, a unified electronic health record that natively embeds Ambient AI (formerly Scribe) for ambient clinical documentation and connects to Athelas Agents — a suite of AI-powered extensions including an Autonomous AI Receptionist, Clinical Agents, and Search Agents — that automate clinical and administrative workflows. Rounding out the portfolio, RCM (Revenue Cycle Management) handles end-to-end billing and claims automation with AI Denial Defense and Remittance Recon Agents, while Athelas Home is a standalone FDA-cleared, CLIA-waived point-of-care hematology analyzer that feeds results directly into the EHR. Underpinning the platform, the Athelas FHIR API (ONC (g)(10) certified, US Core 6.1.0 compliant) provides standardized integration with 60+ EHR systems.

Product and service5 records
1Ambient AI (formerly Scribe)
CategoryClinical Documentation AI
Description

Ambient clinical documentation AI that listens to patient-provider encounters and automatically generates structured clinical notes, CPT/ICD-10 codes, and syncs them to the EHR in real time; targeted at physicians, advanced practice providers, and specialty practices across the U.S.

2Air EHR
CategoryElectronic Health Records
Description

All-in-one electronic health record platform that combines clinical charting, scheduling, patient portal, ambient AI documentation, an autonomous AI receptionist, compliance checks, and embedded revenue cycle management for healthcare practices and large health systems.

3Athelas RCM (Revenue Cycle Management)
CategoryRevenue Cycle Management
Description

End-to-end revenue cycle management platform that automates medical billing, claim submission, denial management with AI Denial Defense, remittance reconciliation via AI agents, patient responsibility collection (SmartPay), and revenue analytics; sold to healthcare practices, FQHCs, urgent care, and large health systems.

4Athelas Home (CLIA-waived Hematology Analyzer)
CategoryPoint-of-Care Diagnostics Hardware
Description

FDA 510(k)-cleared, CLIA-waived AI-powered hematology analyzer that uses an on-device neural-network computer vision model to deliver white blood cell count and neutrophil percentage results from a finger-prick blood sample in minutes; deployed with home patients, ambulatory providers, and pharmacies for chemotherapy, immunosuppressive therapy, and Clozapine monitoring.

5Athelas Agents
CategoryAI Workflow Automation
Description

Suite of AI-powered agents that act as virtual staff for scheduling, billing, appeals, clinical Q&A, and 24/7 patient access via an autonomous AI receptionist; extends the Air EHR and RCM platforms for healthcare practices and large health systems.

Scale indicator16 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierMidTypeStrategic or Co-development PartnerAnnounced on2026-04-28
Description

Athelas is the technology partner for Cape Cod Rehab, providing RCM and EHR capabilities plus workflow automation to reduce administrative burden on clinicians in a physical therapy / rehabilitation setting. Cape Cod Rehab described Athelas as a 'clear choice.'

Strategic tierMidTypeStrategic or Co-development PartnerAnnounced on2026-04-24
Description

Director of Operations AIR Jake Pelligrini describes Athelas' partnership with Rock Valley as a 'true partnership' to push the product to an even greater spot, leveraging Rock Valley's scale and experience to deliver a seamless Air EHR experience.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-04-16
Description

Athelas announced a partnership with Clinekt Health to integrate its automation capabilities with Clinekt's AI-driven patient pre-screening and routing tools for specialty practices. The collaboration aims to create a fully automated pipeline from initial website visit to booked appointment.

Strategic tierMajor (Customer + Referenced Adoption Partner)TypeTechnology or IntegrationAnnounced on2025-05-13
Description

HCA Healthcare is referenced in the Commure 'Future of Medical Coding' blog as a leading health system adopting AI-assisted medical coding, autonomous coding, and real-time decision support technologies integrated with the Commure/Athelas platform.

Strategic tierMajor (Acquisition By Parent)TypeStrategic or Co-development PartnerAnnounced on2024-10-01
Description

Athelas's parent company Commure acquired AI medical scribe platform Augmedix for $139M (announced 2024) following its October 2023 acquisition of Athelas. The two acquisitions demonstrate Commure's strategic push to build out AI capabilities across medical documentation and revenue cycle management.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

AI medical scribe that converts patient-provider conversations into structured clinical notes. Direct competitor to Athelas Ambient AI for ambulatory and specialty practices.

TypeDirect peer
Description

AI voice-enabled clinical assistant that generates notes and documentation for clinicians, with deep EHR integration. Direct competitor in the AI ambient scribe / physician productivity space.

TypeOthers
Description

AI medical scribe platform acquired by Commure (Athelas's parent) for $139M in 2024. Sister company under the same parent, with overlapping ambient AI scribing capabilities and similar specialty-practice customer base.

TypeDirect peer
Description

AI medical documentation platform that ambiently generates clinical notes and integrates with EHRs including Epic. Direct competitor to Athelas's Ambient AI and Athelas Air offerings for health systems and physician practices.

TypeDirect peer
Description

AI-powered medical scribing and ambient documentation platform built for specialty practices. Direct competitor in the AI medical documentation market targeting the same specialty physician customer base.

TypeDirect peer
Description

Integrated EHR, practice management, and RCM platform serving ambulatory practices and FQHCs. Closely comparable bundled offering to Athelas Air + RCM for specialty and mid-market practices.

TypeDirect peer
Description

Cloud-based EHR, practice management, and RCM platform serving physician practices and health systems. Direct competitor across Athelas's EHR + RCM + ambient AI bundle for ambulatory and enterprise customers.

TypeDirect peer
Description

EHR, practice management, and RCM platform focused on specialty ambulatory practices. Closely comparable to Athelas's mid-market specialty practice strategy and product bundling.

TypeDirect peer
Description

End-to-end revenue cycle management services and technology for hospitals and large physician groups. Direct competitor in the RCM segment Athelas serves with its RCM and AI Denial Defense offerings.

TypeDirect peer
Description

Cloud-based revenue cycle management platform for healthcare organizations covering claims management, denials, and patient payments. Direct competitor to Athelas's RCM product line.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat8 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers34 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability13 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds7 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors14 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Athelas

Healthcare Practice Management Softwareathelas.com

Athelas is a Commure-owned healthcare AI subsidiary that provides an integrated platform combining RCM, an EHR (Air), ambient AI scribing, AI agents, and an FDA-cleared hematology analyzer, serving 500+ healthcare organizations across 3,000+ sites of care including HCA and Tenet.

What Athelas does

Athelas is a Mountain View, California-based healthcare AI company operating as a wholly-owned subsidiary of Commure, founded in 2016 and acquired by Commure in October 2023. The company has evolved from its origins in remote patient monitoring into an integrated, AI-native platform spanning five core products: Athelas Air (an EHR with embedded AI receptionist, scheduling, compliance checks, and patient portal), Ambient AI (a clinical documentation co-pilot and autonomous coding layer), RCM (Revenue Cycle Management with AI Denial Defense, Remittance Recon Agents, AI browser agents, and a configurable rules engine running dozens of automations), Athelas Home (an FDA 510(k)-cleared, CLIA-waived point-of-care hematology analyzer using on-device computer vision and a deep-learning model), and Athelas Agents (a suite of autonomous AI agents for scheduling, billing, appeals, and patient outreach). The platform is built on an ONC (g)(10) certified FHIR R4B API with US Core 6.1.0 compliance and integrates with more than 60 EHR systems, processing tens of billions of dollars in annual payments and supporting tens of millions of appointments per year with more than 85% of RCM work completed without a human in the loop.

Athelas serves a dual-segment customer base: large enterprise health systems (130+ of the nation's largest, including HCA Healthcare and Tenet Healthcare) and mid-market specialty physician practices across physical therapy, orthopedics, dermatology, urology, ENT, gastroenterology, urgent care, podiatry, and FQHCs. The company employs 101–250 people (with Forward Deployed Engineering teams supporting implementation), and in May 2026 announced a $70 million financing at a $7 billion post-money valuation led by General Catalyst, with participation from Sequoia Capital, Morgan Stanley, and Kirkland & Ellis, to scale R&D in agentic AI and expand into global healthcare markets.

The business model combines multi-product SaaS subscriptions (Air, Ambient AI, RCM, Agents), performance- and transaction-based RCM fees (denial management, patient collections, SmartPay), and hardware sales for Athelas Home devices deployed in homes, ambulatory settings, and pharmacies. Pricing is custom and quote-based, segmented by provider count and product bundle, sold primarily through direct enterprise field sales, inside-sales for mid-market practices, industry conference presence, and technology partnerships (e.g., Clinekt Health, Cape Cod Rehab). Customer outcomes reported in published case studies include 95% first-pass claim rates, 50% denial reductions, and tens to hundreds of thousands of dollars in monthly revenue gains, supporting land-and-expand economics across multi-site provider groups.

Athelas firmographics

Firmographics
Name
Athelas
Legal name
Athelas, LLC
Website
https://athelas.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
101–250 employees
Short description
Athelas is a Commure-owned healthcare AI subsidiary that provides an integrated platform combining RCM, an EHR (Air), ambient AI scribing, AI agents, and an FDA-cleared hematology analyzer, serving 500+ healthcare organizations across 3,000+ sites of care including HCA and Tenet.
Ownership category
akta.pro rank

Athelas industry classification

Industry
Product category
Healthcare Practice Management Software
NAICS
Software Publishers (513210), Software Publishers (5132)
SIC
Services-Prepackaged Software (7372), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
EHR/EMR Integration & Interoperability Middleware (HL7/FHIR) (HLALAKAD)
akta.pro secondary industries
EHR Extensions, APIs, App Marketplaces & SMART-on-FHIR Apps (HLACAAAN), Medical-Grade Device Connectivity & Device Management (MDM) (HLACAFAG), RPM Reimbursement, Billing & Program Operations Platforms (HLACAFAN)

Keywords

  • Revenue cycle management
  • Electronic health records
  • Ambient clinical documentation
  • AI medical scribing
  • Healthcare automation platform

Where Athelas is headquartered

Location

Headquarters

HQ city
Mountain View
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Athelas business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

  1. Platform Subscription (RCM + Ambient AI + Air EHR + Agents): Recurring SaaS subscriptions across the integrated Athelas/Commure platform covering RCM tools, Ambient AI scribing, the Air EHR, and Athelas Agents, sold as a multi-product platform with upsell across modules.
  2. RCM Managed Services / Performance-based Fees: End-to-end revenue cycle management services for healthcare practices (Athelas RCM), including claim submission, denial management, patient responsibility collections, and reporting; includes performance-driven components tied to collections, recoveries, and automation rates.
  3. Athelas Home Diagnostics Device Sales / Deployment: Revenue tied to the FDA-cleared Athelas Home CLIA-waived hematology analyzer deployed in home and point-of-care settings (ambulatory providers, pharmacies), enabling frequent Absolute Neutrophil Count testing for chemotherapy, immunosuppressive therapy, and Clozapine patients.
  4. Enterprise Health System Licensing: Large-scale enterprise deployments inside health systems (130+ of the largest including HCA Healthcare and Tenet Healthcare), processing tens of billions of dollars in annual payments; includes expansion to global healthcare markets.
  5. Patient Responsibility Collections / SmartPay: Athelas handles patient responsibility collection flows (including SmartPay technology, bulk auto-charging of saved cards, and in-office collection workflows), generating a percentage-based or transaction-based component of revenue tied to patient balances collected.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom quote-based pricing by product bundle and provider count

Go-to-market motion4 records

Distribution channels6 records

Marketing channels8 records

Athelas product offering

Product offering

Core offering

Athelas develops an AI-native healthcare practice platform that unifies revenue cycle management (RCM), an electronic health record (Air EHR), ambient AI clinical documentation, AI workflow agents, and an FDA-cleared CLIA-waived hematology analyzer (Athelas Home). The platform is sold primarily to U.S. health systems and specialty physician practices to automate claims, denial management, charting, scheduling, and patient communications.

Product overview

Athelas operates as a multi-module healthcare AI platform unified under the Commure parent company, with five core product lines that fit together as an integrated offering. The platform centers on Air EHR, a unified electronic health record that natively embeds Ambient AI (formerly Scribe) for ambient clinical documentation and connects to Athelas Agents — a suite of AI-powered extensions including an Autonomous AI Receptionist, Clinical Agents, and Search Agents — that automate clinical and administrative workflows. Rounding out the portfolio, RCM (Revenue Cycle Management) handles end-to-end billing and claims automation with AI Denial Defense and Remittance Recon Agents, while Athelas Home is a standalone FDA-cleared, CLIA-waived point-of-care hematology analyzer that feeds results directly into the EHR. Underpinning the platform, the Athelas FHIR API (ONC (g)(10) certified, US Core 6.1.0 compliant) provides standardized integration with 60+ EHR systems.

Differentiator

Problem solved

Functional benefit

Brands

  • Athelas Ambient AI: Ambient AI scribe and clinical documentation/coding suite (formerly Scribe).
  • Athelas Air
  • Athelas RCM
  • Athelas Home
  • Athelas Agents

Products and services

  • Ambient AI (formerly Scribe) Ambient clinical documentation AI that listens to patient-provider encounters and automatically generates structured clinical notes, CPT/ICD-10 codes, and syncs them to the EHR in real time; targeted at physicians, advanced practice providers, and specialty practices across the U.S.
  • Air EHR All-in-one electronic health record platform that combines clinical charting, scheduling, patient portal, ambient AI documentation, an autonomous AI receptionist, compliance checks, and embedded revenue cycle management for healthcare practices and large health systems.
  • Athelas RCM (Revenue Cycle Management) End-to-end revenue cycle management platform that automates medical billing, claim submission, denial management with AI Denial Defense, remittance reconciliation via AI agents, patient responsibility collection (SmartPay), and revenue analytics; sold to healthcare practices, FQHCs, urgent care, and large health systems.
  • Athelas Home (CLIA-waived Hematology Analyzer) FDA 510(k)-cleared, CLIA-waived AI-powered hematology analyzer that uses an on-device neural-network computer vision model to deliver white blood cell count and neutrophil percentage results from a finger-prick blood sample in minutes; deployed with home patients, ambulatory providers, and pharmacies for chemotherapy, immunosuppressive therapy, and Clozapine monitoring.
  • Athelas Agents Suite of AI-powered agents that act as virtual staff for scheduling, billing, appeals, clinical Q&A, and 24/7 patient access via an autonomous AI receptionist; extends the Air EHR and RCM platforms for healthcare practices and large health systems.

Companies that use Athelas

Customer profile

Named customers34 records

Segments4 records

Ideal customer profiles3 records

Athelas technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability13 records

Feature10 records

Athelas partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered mid, core, major (customer + referenced adoption partner) and major (acquisition by parent).

  • Cape Cod RehabmidStrategic or Co-development Partner · 28 April 2026Athelas is the technology partner for Cape Cod Rehab, providing RCM and EHR capabilities plus workflow automation to reduce administrative burden on clinicians in a physical therapy / rehabilitation setting. Cape Cod Rehab described Athelas as a 'clear choice.'
  • Rock ValleymidStrategic or Co-development Partner · 24 April 2026Director of Operations AIR Jake Pelligrini describes Athelas' partnership with Rock Valley as a 'true partnership' to push the product to an even greater spot, leveraging Rock Valley's scale and experience to deliver a seamless Air EHR experience.
  • Clinekt HealthcoreTechnology or Integration · 16 April 2026Athelas announced a partnership with Clinekt Health to integrate its automation capabilities with Clinekt's AI-driven patient pre-screening and routing tools for specialty practices. The collaboration aims to create a fully automated pipeline from initial website visit to booked appointment.
  • HCA Healthcaremajor (customer + referenced adoption partner)Technology or Integration · 13 May 2025HCA Healthcare is referenced in the Commure 'Future of Medical Coding' blog as a leading health system adopting AI-assisted medical coding, autonomous coding, and real-time decision support technologies integrated with the Commure/Athelas platform.
  • Augmedixmajor (acquisition by parent)Strategic or Co-development Partner · 1 October 2024Athelas's parent company Commure acquired AI medical scribe platform Augmedix for $139M (announced 2024) following its October 2023 acquisition of Athelas. The two acquisitions demonstrate Commure's strategic push to build out AI capabilities across medical documentation and revenue cycle management.

Scale indicators16 records

Recent moves6 records

Expansion highlights6 records

Athelas competitors and assessment

Company assessment

Direct peers

  • Nabla: AI medical scribe that converts patient-provider conversations into structured clinical notes. Direct competitor to Athelas Ambient AI for ambulatory and specialty practices.
  • Suki AI: AI voice-enabled clinical assistant that generates notes and documentation for clinicians, with deep EHR integration. Direct competitor in the AI ambient scribe / physician productivity space.
  • Abridge: AI medical documentation platform that ambiently generates clinical notes and integrates with EHRs including Epic. Direct competitor to Athelas's Ambient AI and Athelas Air offerings for health systems and physician practices.
  • DeepScribe: AI-powered medical scribing and ambient documentation platform built for specialty practices. Direct competitor in the AI medical documentation market targeting the same specialty physician customer base.
  • eClinicalWorks: Integrated EHR, practice management, and RCM platform serving ambulatory practices and FQHCs. Closely comparable bundled offering to Athelas Air + RCM for specialty and mid-market practices.
  • athenahealth: Cloud-based EHR, practice management, and RCM platform serving physician practices and health systems. Direct competitor across Athelas's EHR + RCM + ambient AI bundle for ambulatory and enterprise customers.
  • NextGen Healthcare: EHR, practice management, and RCM platform focused on specialty ambulatory practices. Closely comparable to Athelas's mid-market specialty practice strategy and product bundling.
  • R1 RCM: End-to-end revenue cycle management services and technology for hospitals and large physician groups. Direct competitor in the RCM segment Athelas serves with its RCM and AI Denial Defense offerings.
  • Waystar: Cloud-based revenue cycle management platform for healthcare organizations covering claims management, denials, and patient payments. Direct competitor to Athelas's RCM product line.

Others

  • Augmedix: AI medical scribe platform acquired by Commure (Athelas's parent) for $139M in 2024. Sister company under the same parent, with overlapping ambient AI scribing capabilities and similar specialty-practice customer base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat8 records

Key risks7 records

Key highlights7 records

Customer concentration

Athelas social profiles

Digital presence

Athelas compliance and trust

Trust signal

Compliance4 records

Athelas financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Athelas leadership team

Management profile

Number of profiles

Profiles7 records

Athelas funding detail

Funding detail

Funding overview

Funding rounds7 records

Investors14 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Athelas M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Athelas

What does Athelas do?

Athelas develops an AI-native healthcare practice platform that unifies revenue cycle management (RCM), an electronic health record (Air EHR), ambient AI clinical documentation, AI workflow agents, and an FDA-cleared CLIA-waived hematology analyzer (Athelas Home). The platform is sold primarily to U.S. health systems and specialty physician practices to automate claims, denial management, charting, scheduling, and patient communications.

Is Athelas a public or private company?

Athelas is a private company. It is classified as corporate owned and is currently operating.

When was Athelas founded?

Athelas was founded in 2016. It employs 101 to 250 people.

Where is Athelas based?

Athelas is headquartered in Mountain View, United States, in the North America region.

How does Athelas make money?

Five revenue lines are on record. Platform Subscription (RCM + Ambient AI + Air EHR + Agents) is the primary driver. The others are RCM Managed Services / Performance-based Fees, athelas Home Diagnostics Device Sales / Deployment, enterprise Health System Licensing and patient Responsibility Collections / SmartPay.

Who are Athelas's main competitors?

Direct peers on record are Nabla, Suki AI, Abridge, DeepScribe, eClinicalWorks, athenahealth, NextGen Healthcare, R1 RCM and Waystar. Augmedix is listed as an others.

Does Athelas have an API?

Yes. FHIR R4B-based public API for healthcare data exchange. Features include ONC (g)(10) Standardized API certification, US Core 6.1.0 compliance, and SMART on FHIR App Launch v2.0 support. The API allows developers to read, write, and authenticate clinical data, enabling integration with electronic health record systems. Developer documentation is at docs.athelas.com/developer/api.

What industry is Athelas in?

Athelas's product category is Healthcare Practice Management Software. Its primary akta.pro industry code is HLALAKAD, EHR/EMR Integration & Interoperability Middleware (HL7/FHIR), with a secondary code of HLACAAAN, EHR Extensions, APIs, App Marketplaces & SMART-on-FHIR Apps. Its NAICS code is 513210 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Digital Health NewsAthelas Launches AI-Powered Practice Manager for Billing, Scheduling, and Patient CommunicationAthelas, powered by Commure, has launched Practice Manager, an AI-powered practice management suite designed to automate administrative workflows including billing, scheduling, and patient communication for healthcare providers. The platform integrates payer eligibility checks, claims processing, denial management, and payment posting into a single interface, enabling organizations to process up to 10 times more claims within the same timeframe. Athelas currently supports approximately 7% of healthcare appointments in the United States and processes billions of insurance claims.GlobeNewswireAthelas Launches Practice Manager, the World's First Agentic Practice Management SuiteAthelas launched Practice Manager, its first agentic practice management suite, on Aug. 5, 2026. The suite automates billing, scheduling, and patient communication, enabling teams to process 10x more claims in the same time. It joins Athelas's existing platform, which includes Air EHR and Ambient AI.TipranksAthelas Enhances Platform Security With Role-Based Access ControlAthelas announced the introduction of Role-Based Access Control (RBAC) within its platform, featuring new granular permission settings including facility-level access and four predefined roles (Administrator, Billing Manager, Staff, and Single Provider). The enhancement is designed to improve security, compliance, and operational efficiency for healthcare practices using Athelas's tools. From an investment perspective, such administrative control features may support higher customer retention and upsell opportunities with larger practices and health systems, potentially strengthening Athelas's long-term positioning in the competitive digital health market.TipranksRCM Performance Gains Highlighted in Physical Therapy Case Study for AthelasAthelas highlighted outcomes from Lattimore Physical Therapy and Sports Rehabilitation Network demonstrating the effectiveness of its revenue cycle management tools, with the case study cited on LinkedIn by Clinical Director Tyler Smola. The metrics across 35 locations showed a 95% first-pass claim rate and a 50% reduction in denials, figures that could indicate improved cash flow reliability and reduced administrative burden for provider groups. The article suggests that if similar results are achieved across additional clients, Athelas could strengthen its position in the healthcare RCM segment, where operational gains translate into recurring software revenue and higher switching costs.TipranksHealthcare AI Platform Adoption Highlighted in Orthopedic Practice Case StudyAthelas shared a LinkedIn post in which Raleigh Orthopaedic's COO Ross Rigdon described consolidating 27 physicians, 11 physical therapy sites, and two surgery centers onto a single Athelas AI platform. The post stated this consolidation delivered operational benefits across documentation time, claims processing speed, and staff morale. The article suggests this case study signals traction for Athelas in orthopedics and physical therapy markets, with potential implications for customer retention and expansion to additional multi-site provider groups.TipranksAthelas Highlights Health-Tech Partnership Focused on RCM, EHR and AutomationAthelas is highlighting its role as a technology partner for Cape Cod Rehab, with the physical therapy provider describing Athelas as a “clear choice” based on its focus on growth, automation, and support in a modern healthcare setting. The partnership centers on Athelas’s revenue cycle management and electronic health record capabilities, along with workflow automation designed to reduce administrative burdens on clinicians. The article suggests this positioning reflects a go-to-market motion targeting providers seeking operational leverage in specialized care segments like physical therapy and rehabilitation.TipranksAthelas Partners With Clinekt Health to Automate Specialty Practice IntakeAthelas has announced a partnership with Clinekt Health to integrate its automation capabilities with Clinekt's AI-driven patient pre-screening and routing tools for specialty practices. The collaboration aims to create a fully automated pipeline from initial website visit to booked appointment, reducing administrative burden and enabling practice growth without proportional headcount increases. The partnership may signal Athelas' effort to deepen its role in workflow automation for specialty healthcare providers and expand its addressable market in the health-tech segment.AthelasPediatrics Telehealth Reimbursement: Key 2025 CMS Rules - InsightsThe article discusses CMS rules for pediatrics telehealth reimbursement in 2025. It contains a form from Athelas, Inc. related to an inquiry about practice details.Clinical Lab ProductsFDA Clears Athelas Home AI Blood Test for Point-of-Care SettingsThe FDA has cleared Athelas' CLIA-waived AI-powered hematology analyzer (Athelas Home) for point-of-care use, enabling ambulatory providers and pharmacies to perform white blood cell testing from fingerstick samples without central laboratories. The device uses neural-network-based cell analysis and computer vision to deliver results in minutes, addressing high-risk patients requiring frequent monitoring for chemotherapy, immunosuppressive therapies, and clozapine treatment. The clearance follows four years of regulatory engagement and expands the platform's reach from home settings to clinical environments where same-visit testing can support immediate clinical decisions.GlobeNewswireAthelas Home Expands AI Diagnostics to the Point of Care with FDA ClearanceAthelas, a Commure company, announced FDA clearance for its CLIA-waived Athelas Home AI-powered hematology analyzer to be used in point-of-care settings such as ambulatory providers and pharmacies, enabling same-visit white blood cell and neutrophil percentage testing from a fingerstick. The clearance follows four years of regulatory engagement and expands the device—already used by tens of thousands of patients for home monitoring—into clinical environments to support patients on chemotherapy, immunosuppressive therapies, and Clozapine treatment. The platform is now available for nationwide deployment in point-of-care settings.